Prosecution Insights
Last updated: April 19, 2026

Zymeworks, Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
1
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18612960 Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs HUYNH, PHUONG N 1641 Non-Final OA Mar 21, 2024
18265341 HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF MERTZ, PREMA MARIA 1674 Non-Final OA Jun 05, 2023
18017319 FUSION PROTEINS COMPRISING A LIGAND-RECEPTOR PAIR AND A BIOLOGICALLY FUNCTIONAL PROTEIN LUNDE, GRACE HENRY 1641 Non-Final OA Jan 20, 2023
17999477 IMMUNOGLOBULIN Fc REGION VARIANTS COMPRISING STABILITY-ENHANCING MUTATIONS BRISTOL, LYNN ANNE 1643 Non-Final OA Nov 21, 2022
17919109 ANTIBODY CONSTRUCTS BINDING 4-1BB AND FOLATE RECEPTOR ALPHA AND USES THEREOF SWARTWOUT, BRIANNA KENDALL 1644 Non-Final OA Oct 14, 2022
17914261 MASKED IL12 FUSION PROTEINS AND METHODS OF USE THEREOF PATTERSON, SARAH COOPER 1675 Non-Final OA Sep 23, 2022
17624541 ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS MIDDLETON, DANAYA L 1674 Final Rejection Jan 03, 2022

Managing Zymeworks, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month